Table 1.
Baseline Demographic and Clinical Data from Patients of the Total Cohort. The Age-Adjusted Charlson Comorbidity Index Was Calculated on the Basis of Medical History19
| Clinical Characteristics | All Patients (n=202) |
|---|---|
| Age (years) | 74.4 ± 12.4 |
| Weight (kg) | 76.4 ± 15.2 |
| Height (cm) | 165.1 ± 9.8 |
| Body Mass Index (kg/m2) | 27.9 ± 4.5 |
| Glycosylated A1c hemoglobin (%) | 7.08 ± 1.00 |
| Blood glucose (mg/dL) | 164.7 ± 59.8 |
| Serum hemoglobin (g/dL) | 12.6 ± 1.8 |
| Serum potassium (mEq/L) | 4.43 ± 0.54 |
| Serum creatinine (mg/dL) | 1.00 ± 0.47 |
| Age-adjCharlson Comorbidity Index | 5.21 ± 2.12 |
| Major surgery (%)* | 85.6 (79.9–89.6) |
| Comorbidities (%) | |
| Arterial hypertension (%) | 76.7 (70.2–81.8) |
| Dyslipidemia (%) | 37.1 (30.5–43.7) |
| Coronary artery disease (%) | 17.3 (12.5–22.9) |
| Peripheral vascular disease (%) | 15.8 (11.2–21.2) |
| Chronic kidney disease (%)# | 10.9 (7.1–15.7) |
| Retinopathy (%) | 6.4 (3.6–10.4) |
| Previous cancer (last 5 years)(%) | 12.9 (8.7–17.9) |
| Liver disease (%) | 9.4 (5.9–13.9) |
| Previously diagnosed diabetes (N=183)(%)* | 90.6 (85.5–93.7) |
| Newly-detected diabetes (N=13)(%) | 6.4 (2.8–13.2) |
| Diabetes treatment | |
| Diet only (N=18)(%)° | 9.8 (6.1–14.6) |
| Metformin (N=63)(%)° | 34.4 (27.7–41.3) |
| Any additional non-insulin drug (N=55)(%)° | 29.9 (23.5–36.6) |
| Insulin + any non-insulin treatment (N=21)(%)° | 11.4 (7.4–16.5) |
| Insulin alone (N=26)(%)° | 14.1 (9.8–19.6) |
| Relative hyperglycemia (SHR) | 1.06 ± 0.34 |
| Stress hyperglycemia (SHR >1.14)(N=58)(%)* | 28.9 (22.8–35.2) |
Notes: Data are presented as means ± standard deviation. *Percent (95% confidence interval). #Estimated glomerular filtration rate <60mL/min/1.73m2 (with/without albuminuria). °Percent within diabetes cohort (95% confidence interval).